Johnson & Johnson’s $4.325 Billion Acquisition of Abbott Medical Optics

On September 16, 2016, Johnson & Johnson announced a definitive agreement to acquire Abbott Medical Optics, a wholly owned subsidiary of Abbott Laboratories, for $4.325 billion in cash. The acquisition will include ophthalmic products in three business segments: cataract surgery, laser refractive surgery and consumer eye health. Cravath is representing Johnson & Johnson in connection with the transaction.

The Cravath team is led by partner Robert I. Townsend III and includes associates Peter J. Atlee and Justin B. Stein on M&A matters; partner J. Leonard Teti II and associate Tara L. Rhoades on tax matters; partner Jonathan J. Katz and associates Matthew J. Bobby and Daniel P. Herrmann on executive compensation and benefits matters; partner David J. Kappos and associate Jason M. Sandler on intellectual property matters; and partner Matthew Morreale on environmental matters.